TY - JOUR AU - Sgalla, G. AU - Biffi, A. AU - Richeldi, L. PY - 2016 DA - 2016// TI - Idiopathic pulmonary fibrosis: diagnosis, epidemiology and natural history JO - Respirology VL - 21 UR - https://doi.org/10.1111/resp.12683 DO - 10.1111/resp.12683 ID - Sgalla2016 ER - TY - JOUR AU - Collard, H. R. AU - Ryerson, C. J. AU - Corte, T. J. AU - Jenkins, G. AU - Kondoh, Y. AU - Lederer, D. J. AU - Lee, J. S. AU - Maher, T. M. AU - Wells, A. U. AU - Antoniou, K. M. PY - 2016 DA - 2016// TI - Acute exacerbation of idiopathic pulmonary fibrosis. An international working group report JO - Am J Respir Crit Care Med VL - 194 UR - https://doi.org/10.1164/rccm.201604-0801CI DO - 10.1164/rccm.201604-0801CI ID - Collard2016 ER - TY - JOUR AU - Raghu, G. AU - Collard, H. R. AU - Anstrom, K. J. AU - Flaherty, K. R. AU - Fleming, T. R. AU - King, T. E. AU - Martinez, F. J. AU - Brown, K. K. PY - 2012 DA - 2012// TI - Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials JO - Am J Respir Crit Care Med VL - 185 UR - https://doi.org/10.1164/rccm.201201-0006PP DO - 10.1164/rccm.201201-0006PP ID - Raghu2012 ER - TY - JOUR AU - Ley, B. AU - Swigris, J. AU - Day, B. M. AU - Stauffer, J. L. AU - Raimundo, K. AU - Chou, W. AU - Collard, H. R. PY - 2017 DA - 2017// TI - Pirfenidone reduces respiratory-related hospitalizations in idiopathic pulmonary fibrosis JO - Am J Respir Crit Care Med VL - 196 UR - https://doi.org/10.1164/rccm.201701-0091OC DO - 10.1164/rccm.201701-0091OC ID - Ley2017 ER - TY - JOUR AU - Collard, H. R. AU - Brown, K. K. AU - Martinez, F. J. AU - Raghu, G. AU - Roberts, R. S. AU - Anstrom, K. J. PY - 2014 DA - 2014// TI - Study design implications of death and hospitalization as end points in idiopathic pulmonary fibrosis JO - Chest VL - 146 UR - https://doi.org/10.1378/chest.14-0492 DO - 10.1378/chest.14-0492 ID - Collard2014 ER - TY - JOUR AU - Nathan, S. D. AU - Albera, C. AU - Bradford, W. Z. AU - Costabel, U. AU - Glaspole, I. AU - Glassberg, M. K. AU - Kardatzke, D. R. AU - Daigl, M. AU - Kirchgaessler, K. U. AU - Lancaster, L. H. PY - 2017 DA - 2017// TI - Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis JO - Lancet Respir Med VL - 5 UR - https://doi.org/10.1016/S2213-2600(16)30326-5 DO - 10.1016/S2213-2600(16)30326-5 ID - Nathan2017 ER - TY - JOUR AU - Durheim, M. T. AU - Collard, H. R. AU - Roberts, R. S. AU - Brown, K. K. AU - Flaherty, K. R. AU - King, T. E. AU - Palmer, S. M. AU - Raghu, G. AU - Snyder, L. D. AU - Anstrom, K. J. PY - 2015 DA - 2015// TI - Association of hospital admission and forced vital capacity endpoints with survival in patients with idiopathic pulmonary fibrosis: analysis of a pooled cohort from three clinical trials JO - Lancet Respir Med VL - 3 UR - https://doi.org/10.1016/S2213-2600(15)00093-4 DO - 10.1016/S2213-2600(15)00093-4 ID - Durheim2015 ER - TY - JOUR AU - Raghu, G. AU - Selman, M. PY - 2015 DA - 2015// TI - Nintedanib and pirfenidone. New antifibrotic treatments indicated for idiopathic pulmonary fibrosis offer hopes and raises questions JO - Am J Respir Crit Care Med VL - 191 UR - https://doi.org/10.1164/rccm.201411-2044ED DO - 10.1164/rccm.201411-2044ED ID - Raghu2015 ER - TY - STD TI - Collard HR, Richeldi L, Kim DS, Taniguchi H, Tschoepe I, Luisetti M, Roman J, Tino G, Schlenker-Herceg R, Hallmann C, du Bois RM. Acute exacerbations in the INPULSIS trials of nintedanib in idiopathic pulmonary fibrosis. Eur Respir J. 2017;49(5):1601339. ID - ref9 ER - TY - JOUR AU - Dempsey, T. M. AU - Sangaralingham, L. R. AU - Yao, X. AU - Sanghavi, D. AU - Shah, N. D. AU - Limper, A. H. PY - 2019 DA - 2019// TI - Clinical effectiveness of Antifibrotic medications for idiopathic pulmonary fibrosis JO - Am J Respir Crit Care Med VL - 200 UR - https://doi.org/10.1164/rccm.201902-0456OC DO - 10.1164/rccm.201902-0456OC ID - Dempsey2019 ER - TY - STD TI - Fisher M, Nathan SD, Hill C, Marshall J, Dejonckheere F, Thuresson PO, Maher TM: Predicting Life Expectancy for Pirfenidone in Idiopathic Pulmonary Fibrosis. J Manag Care Spec Pharm 2017, 23(3-b Suppl):S17-S24. ID - ref11 ER - TY - JOUR AU - Richeldi, L. AU - Bois, R. M. AU - Raghu, G. AU - Azuma, A. AU - Brown, K. K. AU - Costabel, U. AU - Cottin, V. AU - Flaherty, K. R. AU - Hansell, D. M. AU - Inoue, Y. PY - 2014 DA - 2014// TI - Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis JO - N Engl J Med VL - 370 UR - https://doi.org/10.1056/NEJMoa1402584 DO - 10.1056/NEJMoa1402584 ID - Richeldi2014 ER - TY - JOUR AU - Kreuter, M. AU - Koegler, H. AU - Trampisch, M. AU - Geier, S. AU - Richeldi, L. PY - 2019 DA - 2019// TI - Differing severities of acute exacerbations of idiopathic pulmonary fibrosis (IPF): insights from the INPULSIS(R) trials JO - Respir Res VL - 20 UR - https://doi.org/10.1186/s12931-019-1037-7 DO - 10.1186/s12931-019-1037-7 ID - Kreuter2019 ER - TY - JOUR AU - Flaherty, K. R. AU - Andrei, A. C. AU - King, T. E. AU - Raghu, G. AU - Colby, T. V. AU - Wells, A. AU - Bassily, N. AU - Brown, K. AU - Bois, R. AU - Flint, A. PY - 2007 DA - 2007// TI - Idiopathic interstitial pneumonia: do community and academic physicians agree on diagnosis? JO - Am J Respir Crit Care Med VL - 175 UR - https://doi.org/10.1164/rccm.200606-833OC DO - 10.1164/rccm.200606-833OC ID - Flaherty2007 ER - TY - JOUR AU - Lamas, D. J. AU - Kawut, S. M. AU - Bagiella, E. AU - Philip, N. AU - Arcasoy, S. M. AU - Lederer, D. J. PY - 2011 DA - 2011// TI - Delayed access and survival in idiopathic pulmonary fibrosis: a cohort study JO - Am J Respir Crit Care Med VL - 184 UR - https://doi.org/10.1164/rccm.201104-0668OC DO - 10.1164/rccm.201104-0668OC ID - Lamas2011 ER - TY - JOUR AU - Raghu, G. AU - Anstrom, K. J. AU - King, T. E. AU - Lasky, J. A. AU - Martinez, F. J. PY - 2012 DA - 2012// TI - Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis JO - N Engl J Med VL - 366 UR - https://doi.org/10.1056/NEJMoa1113354 DO - 10.1056/NEJMoa1113354 ID - Raghu2012 ER - TY - STD TI - HCUP Quality control procedures. Healthcare Cost and Utilization Project (HCUP) [www.hcup-us.ahrq.gov/db/quality.jsp]. Accessed 14 April 2020. UR - http://www.hcup-us.ahrq.gov/db/quality.jsp ID - ref17 ER - TY - STD TI - Vu A, Vasireddy A, Moua T, Baqir M, Ryu JH. Clarifying the diagnosis of post-inflammatory pulmonary fibrosis: a population-based study. Eur Respir J. 2019;54(1):1900103. ID - ref18 ER - TY - STD TI - Clinical Classifications Software Refined (CCSR) for ICD-10-CM Diagnoses. Healthcare Cost and Utilization Project (HCUP) [www.hcup-us.ahrq.gov/toolssoftware/ccsr/ccs_refined.jsp] . Accessed 14 April 2020. UR - http://www.hcup-us.ahrq.gov/toolssoftware/ccsr/ccs_refined.jsp ID - ref19 ER - TY - STD TI - HCUP Clinical classifications software (CCS) for ICD-9-CM. Healthcare Cost and Utilization Project (HCUP) [www.hcup-us.ahrq.gov/toolssoftware/ccs/ccs.jsp] . Accessed 14 April 2020. UR - http://www.hcup-us.ahrq.gov/toolssoftware/ccs/ccs.jsp ID - ref20 ER - TY - STD TI - HCUP Clinical classifications software for services and procedures. Healthcare Cost and Utilization Project (HCUP) [https://www.hcup-us.ahrq.gov/toolssoftware/ccs_svcsproc/ccssvcproc.jsp] . Accessed 14 April 2020. UR - https://www.hcup-us.ahrq.gov/toolssoftware/ccs_svcsproc/ccssvcproc.jsp ID - ref21 ER - TY - STD TI - HCUP Comorbidity software. Healthcare Cost and Utilization Project (HCUP) [https://www.hcup-us.ahrq.gov/toolssoftware/comorbidity/comorbidity.jsp]. Accessed 14 April 2020. UR - https://www.hcup-us.ahrq.gov/toolssoftware/comorbidity/comorbidity.jsp ID - ref22 ER - TY - STD TI - Caminati A, Lonati C, Cassandro R, Elia D, Pelosi G, Torre O, Zompatori M, Uslenghi E, Harari S. Comorbidities in idiopathic pulmonary fibrosis: an underestimated issue. Eur Respir Rev. 2019;28(153):190044. ID - ref23 ER - TY - JOUR AU - Kreuter, M. AU - Ehlers-Tenenbaum, S. AU - Palmowski, K. AU - Bruhwyler, J. AU - Oltmanns, U. AU - Muley, T. AU - Heussel, C. P. AU - Warth, A. AU - Kolb, M. AU - Herth, F. J. PY - 2016 DA - 2016// TI - Impact of comorbidities on mortality in patients with idiopathic pulmonary fibrosis JO - PLoS One VL - 11 UR - https://doi.org/10.1371/journal.pone.0151425 DO - 10.1371/journal.pone.0151425 ID - Kreuter2016 ER - TY - JOUR AU - Oldham, J. M. AU - Collard, H. R. PY - 2017 DA - 2017// TI - Comorbid conditions in idiopathic pulmonary fibrosis: recognition and management JO - Front Med (Lausanne) VL - 4 UR - https://doi.org/10.3389/fmed.2017.00123 DO - 10.3389/fmed.2017.00123 ID - Oldham2017 ER - TY - BOOK AU - Tabachnick, B. G. AU - Fidell, L. S. PY - 2013 DA - 2013// TI - Using multivariate statistics PB - Pearson Education CY - Boston ID - Tabachnick2013 ER - TY - JOUR AU - Hutchinson, J. AU - Fogarty, A. AU - Hubbard, R. AU - McKeever, T. PY - 2015 DA - 2015// TI - Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review JO - Eur Respir J VL - 46 UR - https://doi.org/10.1183/09031936.00185114 DO - 10.1183/09031936.00185114 ID - Hutchinson2015 ER - TY - JOUR AU - Raghu, G. AU - Chen, S. Y. AU - Yeh, W. S. AU - Maroni, B. AU - Li, Q. AU - Lee, Y. C. AU - Collard, H. R. PY - 2014 DA - 2014// TI - Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001-11 JO - Lancet Respir Med VL - 2 UR - https://doi.org/10.1016/S2213-2600(14)70101-8 DO - 10.1016/S2213-2600(14)70101-8 ID - Raghu2014 ER - TY - JOUR AU - Rush, B. AU - Wiskar, K. AU - Berger, L. AU - Griesdale, D. PY - 2016 DA - 2016// TI - The use of mechanical ventilation in patients with idiopathic pulmonary fibrosis in the United States: a nationwide retrospective cohort analysis JO - Respir Med VL - 111 UR - https://doi.org/10.1016/j.rmed.2015.12.005 DO - 10.1016/j.rmed.2015.12.005 ID - Rush2016 ER - TY - JOUR AU - Durheim, M. T. AU - Judy, J. AU - Bender, S. AU - Baumer, D. AU - Lucas, J. AU - Robinson, S. B. AU - Mohamedaly, O. AU - Shah, B. R. AU - Leonard, T. AU - Conoscenti, C. S. PY - 2019 DA - 2019// TI - In-hospital mortality in patients with idiopathic pulmonary fibrosis: a US cohort study JO - Lung VL - 197 UR - https://doi.org/10.1007/s00408-019-00270-z DO - 10.1007/s00408-019-00270-z ID - Durheim2019 ER - TY - JOUR AU - Dove, E. P. AU - Olson, A. L. AU - Glassberg, M. K. PY - 2019 DA - 2019// TI - Trends in idiopathic pulmonary fibrosis-related mortality in the United States: 2000-2017 JO - Am J Respir Crit Care Med VL - 200 UR - https://doi.org/10.1164/rccm.201905-0958LE DO - 10.1164/rccm.201905-0958LE ID - Dove2019 ER - TY - STD TI - Fernández Pérez ER. Changing trends in age-adjusted pulmonary fibrosis mortality in the USA: a joinpoint regression analysis. Eur Respir J. 2019;54(1):1900364. ID - ref32 ER - TY - JOUR AU - Ho, A. T. N. AU - Shmelev, A. AU - Charbek, E. PY - 2020 DA - 2020// TI - Trends and seasonal variation of hospitalization and mortality of interstitial lung disease in the United States from 2006 to 2016 JO - Respir Res VL - 21 UR - https://doi.org/10.1186/s12931-020-01421-0 DO - 10.1186/s12931-020-01421-0 ID - Ho2020 ER - TY - JOUR AU - Raghu, G. AU - Rochwerg, B. AU - Zhang, Y. AU - Garcia, C. A. AU - Azuma, A. AU - Behr, J. AU - Brozek, J. L. AU - Collard, H. R. AU - Cunningham, W. AU - Homma, S. PY - 2015 DA - 2015// TI - An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline JO - Am J Respir Crit Care Med VL - 192 UR - https://doi.org/10.1164/rccm.201506-1063ST DO - 10.1164/rccm.201506-1063ST ID - Raghu2015 ER - TY - STD TI - Richeldi L, Launders N, Martinez F, et al. The characterisation of interstitial lung disease multidisciplinary team meetings: a global study. ERJ Open Res. 2019;5(2):00209–2018. ID - ref35 ER - TY - JOUR AU - Mooney, J. J. AU - Raimundo, K. AU - Chang, E. AU - Broder, M. S. PY - 2017 DA - 2017// TI - Mechanical ventilation in idiopathic pulmonary fibrosis: a nationwide analysis of ventilator use, outcomes, and resource burden JO - BMC Pulm Med VL - 17 UR - https://doi.org/10.1186/s12890-017-0426-2 DO - 10.1186/s12890-017-0426-2 ID - Mooney2017 ER - TY - JOUR AU - Karkkainen, M. AU - Kettunen, H. P. AU - Nurmi, H. AU - Selander, T. AU - Purokivi, M. AU - Kaarteenaho, R. PY - 2017 DA - 2017// TI - Effect of smoking and comorbidities on survival in idiopathic pulmonary fibrosis JO - Respir Res VL - 18 UR - https://doi.org/10.1186/s12931-017-0642-6 DO - 10.1186/s12931-017-0642-6 ID - Karkkainen2017 ER - TY - JOUR AU - King, T. E. AU - Bradford, W. Z. AU - Castro-Bernardini, S. AU - Fagan, E. A. AU - Glaspole, I. AU - Glassberg, M. K. AU - Gorina, E. AU - Hopkins, P. M. AU - Kardatzke, D. AU - Lancaster, L. PY - 2014 DA - 2014// TI - A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis JO - N Engl J Med VL - 370 UR - https://doi.org/10.1056/NEJMoa1402582 DO - 10.1056/NEJMoa1402582 ID - King2014 ER - TY - JOUR AU - Ley, B. AU - Collard, H. R. AU - King, T. E. PY - 2011 DA - 2011// TI - Clinical course and prediction of survival in idiopathic pulmonary fibrosis JO - Am J Respir Crit Care Med VL - 183 UR - https://doi.org/10.1164/rccm.201006-0894CI DO - 10.1164/rccm.201006-0894CI ID - Ley2011 ER - TY - STD TI - Adegunsoye A, Oldham JM, Bellam SK, et al. African-American race and mortality in interstitial lung disease: a multicentre propensity-matched analysis. Eur Respir J. 2018;51(6):1800255. ID - ref40 ER - TY - JOUR AU - Yamazaki, R. AU - Nishiyama, O. AU - Sano, H. AU - Iwanaga, T. AU - Higashimoto, Y. AU - Kume, H. AU - Tohda, Y. PY - 2016 DA - 2016// TI - Clinical features and outcomes of IPF patients hospitalized for pulmonary infection: a Japanese cohort study JO - PLoS One VL - 11 UR - https://doi.org/10.1371/journal.pone.0168164 DO - 10.1371/journal.pone.0168164 ID - Yamazaki2016 ER - TY - STD TI - Pugashetti J, Graham J, Boctor N, Mendez C, Foster E, Juarez M, Harper R, Morrissey B, Kadoch M, Oldham JM. Weight loss as a predictor of mortality in patients with interstitial lung disease. Eur Respir J. 2018;52(3):1801289. ID - ref42 ER - TY - JOUR AU - Sprunger, D. B. AU - Olson, A. L. AU - Huie, T. J. AU - Fernandez-Perez, E. R. AU - Fischer, A. AU - Solomon, J. J. AU - Brown, K. K. AU - Swigris, J. J. PY - 2012 DA - 2012// TI - Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease JO - Eur Respir J VL - 39 UR - https://doi.org/10.1183/09031936.00041411 DO - 10.1183/09031936.00041411 ID - Sprunger2012 ER - TY - JOUR AU - Alakhras, M. AU - Decker, P. A. AU - Nadrous, H. F. AU - Collazo-Clavell, M. AU - Ryu, J. H. PY - 2007 DA - 2007// TI - Body mass index and mortality in patients with idiopathic pulmonary fibrosis JO - Chest VL - 131 UR - https://doi.org/10.1378/chest.06-2784 DO - 10.1378/chest.06-2784 ID - Alakhras2007 ER - TY - JOUR AU - Hyldgaard, C. AU - Hilberg, O. AU - Bendstrup, E. PY - 2014 DA - 2014// TI - How does comorbidity influence survival in idiopathic pulmonary fibrosis? JO - Respir Med VL - 108 UR - https://doi.org/10.1016/j.rmed.2014.01.008 DO - 10.1016/j.rmed.2014.01.008 ID - Hyldgaard2014 ER - TY - JOUR AU - Kolilekas, L. AU - Manali, E. AU - Vlami, K. A. AU - Lyberopoulos, P. AU - Triantafillidou, C. AU - Kagouridis, K. AU - Baou, K. AU - Gyftopoulos, S. AU - Vougas, K. N. AU - Karakatsani, A. PY - 2013 DA - 2013// TI - Sleep oxygen desaturation predicts survival in idiopathic pulmonary fibrosis JO - J Clin Sleep Med VL - 9 UR - https://doi.org/10.5664/jcsm.2758 DO - 10.5664/jcsm.2758 ID - Kolilekas2013 ER - TY - JOUR AU - Kaunisto, J. AU - Kelloniemi, K. AU - Sutinen, E. AU - Hodgson, U. AU - Piilonen, A. AU - Kaarteenaho, R. AU - Makitaro, R. AU - Purokivi, M. AU - Lappi-Blanco, E. AU - Saarelainen, S. PY - 2015 DA - 2015// TI - Re-evaluation of diagnostic parameters is crucial for obtaining accurate data on idiopathic pulmonary fibrosis JO - BMC Pulm Med VL - 15 UR - https://doi.org/10.1186/s12890-015-0074-3 DO - 10.1186/s12890-015-0074-3 ID - Kaunisto2015 ER - TY - STD TI - Wu X, Kim GH, Salisbury ML, Barber D, Bartholmai BJ, Brown KK, Conoscenti CS, De Backer J, Flaherty KR, Gruden JF, Hoffman EA, Humphries SM, Jacob J, Maher TM, Raghu G, Richeldi L, Ross BD, Schlenker-Herceg R, Sverzellati N, Wells AU, Martinez FJ, Lynch DA, Goldin J, Walsh SLF. Computed Tomographic Biomarkers in Idiopathic Pulmonary Fibrosis. The Future of Quantitative Analysis. Am J Respir Crit Care Med. 2019;199(1):12–21. ID - ref48 ER - TY - JOUR AU - Lancaster, L. AU - Crestani, B. AU - Hernandez, P. AU - Inoue, Y. AU - Wachtlin, D. AU - Loaiza, L. AU - Quaresma, M. AU - Stowasser, S. AU - Richeldi, L. PY - 2019 DA - 2019// TI - Safety and survival data in patients with idiopathic pulmonary fibrosis treated with nintedanib: pooled data from six clinical trials JO - BMJ Open Respir Res VL - 6 UR - https://doi.org/10.1136/bmjresp-2018-000397 DO - 10.1136/bmjresp-2018-000397 ID - Lancaster2019 ER -